NM_000321.3:c.1390-11A>G

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000321.3(RB1):​c.1390-11A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000671 in 1,198,044 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0034 ( 7 hom., cov: 30)
Exomes 𝑓: 0.00031 ( 1 hom. )

Consequence

RB1
NM_000321.3 intron

Scores

2
Splicing: ADA: 0.00007313
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: 1.05
Variant links:
Genes affected
RB1 (HGNC:9884): (RB transcriptional corepressor 1) The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 13-48380042-A-G is Benign according to our data. Variant chr13-48380042-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 255821.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=5, Uncertain_significance=1}. Variant chr13-48380042-A-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00336 (481/143254) while in subpopulation AFR AF= 0.012 (466/38948). AF 95% confidence interval is 0.0111. There are 7 homozygotes in gnomad4. There are 221 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High AC in GnomAd4 at 481 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RB1NM_000321.3 linkc.1390-11A>G intron_variant Intron 14 of 26 ENST00000267163.6 NP_000312.2 P06400A0A024RDV3
RB1NM_001407165.1 linkc.1390-11A>G intron_variant Intron 14 of 26 NP_001394094.1
RB1NM_001407166.1 linkc.1390-11A>G intron_variant Intron 14 of 16 NP_001394095.1
LOC112268118XR_002957522.2 linkn.-168T>C upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RB1ENST00000267163.6 linkc.1390-11A>G intron_variant Intron 14 of 26 1 NM_000321.3 ENSP00000267163.4 P06400
RB1ENST00000650461.1 linkc.1390-11A>G intron_variant Intron 14 of 26 ENSP00000497193.1 A0A3B3IS71

Frequencies

GnomAD3 genomes
AF:
0.00337
AC:
483
AN:
143206
Hom.:
7
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0120
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000354
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000220
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000910
Gnomad OTH
AF:
0.00204
GnomAD3 exomes
AF:
0.000596
AC:
68
AN:
114180
Hom.:
1
AF XY:
0.000530
AC XY:
34
AN XY:
64186
show subpopulations
Gnomad AFR exome
AF:
0.00833
Gnomad AMR exome
AF:
0.000481
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000605
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000837
Gnomad OTH exome
AF:
0.00142
GnomAD4 exome
AF:
0.000306
AC:
323
AN:
1054790
Hom.:
1
Cov.:
19
AF XY:
0.000256
AC XY:
135
AN XY:
526366
show subpopulations
Gnomad4 AFR exome
AF:
0.0107
Gnomad4 AMR exome
AF:
0.000793
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000335
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000265
Gnomad4 OTH exome
AF:
0.00127
GnomAD4 genome
AF:
0.00336
AC:
481
AN:
143254
Hom.:
7
Cov.:
30
AF XY:
0.00318
AC XY:
221
AN XY:
69490
show subpopulations
Gnomad4 AFR
AF:
0.0120
Gnomad4 AMR
AF:
0.000353
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000910
Gnomad4 OTH
AF:
0.00202
Alfa
AF:
0.00144
Hom.:
0
Bravo
AF:
0.00379

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Retinoblastoma Benign:4
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 28, 2022
Color Diagnostics, LLC DBA Color Health
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 05, 2024
All of Us Research Program, National Institutes of Health
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

RB1: BS1, BS2 -

Mar 04, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary cancer-predisposing syndrome Uncertain:1
Oct 21, 2014
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.1390-11A>G intronic variant results from an A to G substitution 11 nucleotides upstream from coding exon 15 in the RB1 gene. This variant was previously reported in the SNPDatabase as rs200658795. Based on data from the 1000 Genomes Project, the G allele has an overall frequency of approximately 0.1% (2/2,098) total alleles studied. The highest observed frequency was 0.57% (1/176) Yoruba alleles. Based on data from the NHLBI Exome Sequencing Project (ESP), the G allele has an overall frequency of approximately 0.22% (23/10,564) total alleles studied, having been observed in 0.7% (23/3,288) African American alleles. To date, this alteration has been detected with an allele frequency of approximately 0.29% (greater than 350 alleles tested) in our clinical cohort. This amino acid position is not well conserved in available vertebrate species. Using two different splice site prediction tools, this alteration does not have any significant effect on this splice donor site (http://www.fruitfly.org/seq_tools/splice.html and http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi). However, experimental evidence is not available. Since supporting evidence is limited at this time, the clinical significance of c.1390-11A>G remains unclear. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
15
DANN
Benign
0.84
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000073
dbscSNV1_RF
Benign
0.084
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200658795; hg19: chr13-48954178; API